157 related articles for article (PubMed ID: 22525741)
1. Characterization of urinary bile acids in a pediatric BRIC-1 patient: effect of rifampicin treatment.
Mizuochi T; Kimura A; Tanaka A; Muto A; Nittono H; Seki Y; Takahashi T; Kurosawa T; Kage M; Takikawa H; Matsuishi T
Clin Chim Acta; 2012 Aug; 413(15-16):1301-4. PubMed ID: 22525741
[TBL] [Abstract][Full Text] [Related]
2. Characterization of mutations in ATP8B1 associated with hereditary cholestasis.
Klomp LW; Vargas JC; van Mil SW; Pawlikowska L; Strautnieks SS; van Eijk MJ; Juijn JA; Pabón-Peña C; Smith LB; DeYoung JA; Byrne JA; Gombert J; van der Brugge G; Berger R; Jankowska I; Pawlowska J; Villa E; Knisely AS; Thompson RJ; Freimer NB; Houwen RH; Bull LN
Hepatology; 2004 Jul; 40(1):27-38. PubMed ID: 15239083
[TBL] [Abstract][Full Text] [Related]
3. Successful treatment with colestimide for a bout of cholestasis in a Japanese patient with benign recurrent intrahepatic cholestasis caused by ATP8B1 mutation.
Uegaki S; Tanaka A; Mori Y; Kodama H; Fukusato T; Takikawa H
Intern Med; 2008; 47(7):599-602. PubMed ID: 18379143
[TBL] [Abstract][Full Text] [Related]
4. Benign recurrent intrahepatic cholestasis: altered bile acid metabolism.
Bijleveld CM; Vonk RJ; Kuipers F; Havinga R; Boverhof R; Koopman BJ; Wolthers BG; Fernandes J
Gastroenterology; 1989 Aug; 97(2):427-32. PubMed ID: 2744357
[TBL] [Abstract][Full Text] [Related]
5. Benign recurrent intrahepatic cholestasis: review and long-term follow-up of five cases.
Folvik G; Hilde O; Helge GO
Scand J Gastroenterol; 2012 Apr; 47(4):482-8. PubMed ID: 22229830
[TBL] [Abstract][Full Text] [Related]
6. A mouse genetic model for familial cholestasis caused by ATP8B1 mutations reveals perturbed bile salt homeostasis but no impairment in bile secretion.
Pawlikowska L; Groen A; Eppens EF; Kunne C; Ottenhoff R; Looije N; Knisely AS; Killeen NP; Bull LN; Elferink RP; Freimer NB
Hum Mol Genet; 2004 Apr; 13(8):881-92. PubMed ID: 14976163
[TBL] [Abstract][Full Text] [Related]
7. [Abnormal bile acids in benign recurrent intrahepatic cholestasis].
Endo T
Nihon Rinsho; 1984 Jul; 42(7):1618-24. PubMed ID: 6492403
[No Abstract] [Full Text] [Related]
8. ATP8B1 and ATP11C: Two Lipid Flippases Important for Hepatocyte Function.
Naik J; de Waart DR; Utsunomiya K; Duijst S; Mok KH; Oude Elferink RP; Bosma PJ; Paulusma CC
Dig Dis; 2015; 33(3):314-8. PubMed ID: 26045263
[TBL] [Abstract][Full Text] [Related]
9. Hydroxylation of cholic, chenodeoxycholic, and deoxycholic acids in patients with intrahepatic cholestasis.
Bremmelgaard A; Sjövall J
J Lipid Res; 1980 Nov; 21(8):1072-81. PubMed ID: 7462803
[TBL] [Abstract][Full Text] [Related]
10. Serum bile acid concentrations in the course of benign recurrent intrahepatic cholestasis.
Finni K; Similä S; Heikura S; Jänne O; Mäentausta O
Ann Clin Res; 1980 Aug; 12(4):168-71. PubMed ID: 7259083
[TBL] [Abstract][Full Text] [Related]
11. Cytoprotective properties of rifampicin are related to the regulation of detoxification system and bile acid transporter expression during hepatocellular injury induced by hydrophobic bile acids.
González R; Cruz A; Ferrín G; López-Cillero P; Briceño J; Gómez MA; Rufián S; Padillo J; De la Mata M; Marin JJ; Muntané J
J Hepatobiliary Pancreat Sci; 2011 Sep; 18(5):740-50. PubMed ID: 21526375
[TBL] [Abstract][Full Text] [Related]
12. FIC1 disease: a spectrum of intrahepatic cholestatic disorders.
van Mil SW; Klomp LW; Bull LN; Houwen RH
Semin Liver Dis; 2001 Nov; 21(4):535-44. PubMed ID: 11745041
[TBL] [Abstract][Full Text] [Related]
13. Profile of urinary bile acids in familial intrahepatic cholestasis with Coombs' negative haemolytic anaemia.
Kimura A; Ushijima K; Suzuki M; Tohma M; Inokuchi T; Kato H
Acta Paediatr; 1995 Oct; 84(10):1119-24. PubMed ID: 8563222
[TBL] [Abstract][Full Text] [Related]
14. Rifampicin in the treatment of severe intrahepatic cholestasis of pregnancy.
Geenes V; Chambers J; Khurana R; Shemer EW; Sia W; Mandair D; Elias E; Marschall HU; Hague W; Williamson C
Eur J Obstet Gynecol Reprod Biol; 2015 Jun; 189():59-63. PubMed ID: 25864112
[TBL] [Abstract][Full Text] [Related]
15. Benign recurrent intrahepatic cholestasis: a long-term follow-up.
Nakamuta M; Sakamoto S; Miyata Y; Sato M; Nawata H
Hepatogastroenterology; 1994 Jun; 41(3):287-9. PubMed ID: 7959556
[TBL] [Abstract][Full Text] [Related]
16. Failure of ursodeoxycholic acid to prevent a cholestatic episode in a patient with benign recurrent intrahepatic cholestasis: a study of bile acid metabolism.
Crosignani A; Podda M; Bertolini E; Battezzati PM; Zuin M; Setchell KD
Hepatology; 1991 Jun; 13(6):1076-83. PubMed ID: 2050325
[TBL] [Abstract][Full Text] [Related]
17. Progressive familial intrahepatic cholestasis.
Cavestro GM; Frulloni L; Cerati E; Ribeiro LA; Corrente V; Sianesi M; Franzè A; Di Mario F
Acta Biomed; 2002; 73(3-4):53-6. PubMed ID: 12596388
[TBL] [Abstract][Full Text] [Related]
18. Benign recurrent intrahepatic cholestasis: late initial diagnosis in adulthood.
Ermis F; Oncu K; Ozel M; Yazgan Y; Gurbuz AK; Demirturk L; Demirci H; Akyol T; Hahoglu A
Ann Hepatol; 2010; 9(2):207-10. PubMed ID: 20526019
[TBL] [Abstract][Full Text] [Related]
19. A gene encoding a P-type ATPase mutated in two forms of hereditary cholestasis.
Bull LN; van Eijk MJ; Pawlikowska L; DeYoung JA; Juijn JA; Liao M; Klomp LW; Lomri N; Berger R; Scharschmidt BF; Knisely AS; Houwen RH; Freimer NB
Nat Genet; 1998 Mar; 18(3):219-24. PubMed ID: 9500542
[TBL] [Abstract][Full Text] [Related]
20. Bile acid metabolism in benign recurrent intrahepatic cholestasis. Comparative studies on the icteric and anicteric phases of a single case.
Endo T; Uchida K; Amuro Y; Higashino K; Yamamura Y
Gastroenterology; 1979 May; 76(5 Pt 1):1002-6. PubMed ID: 437403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
